Showing results (1-10 of 71) with videos related to
Sort By:
Pageof 8
Prostaglandins, Leukotrienes, and Essential Fatty Acids|September 24, 2004
Ethyl-EPA in Alzheimer's disease--a pilot studyPaul F Boston, Amanda Bennett, David F Horrobin, et al.Human Psychopharmacology|October 31, 2002
Phospholipid metabolism and depression: the possible roles of phospholipase A2 and coenzyme A-independent transacylaseDavid F HorrobinProgress in Drug Research. Fortschritte Der Arzneimittelforschung. Progres Des Recherches Pharmaceutiques|December 3, 2002
A new category of psychotropic drugs: neuroactive lipids as exemplified by ethyl eicosapentaenoate (E-E)David F HorrobinMedical Hypotheses|April 25, 2003
A low toxicity maintenance regime, using eicosapentaenoic acid and readily available drugs, for mantle cell lymphoma and other malignancies with excess cyclin D1 levelsDavid F HorrobinJournal of Psychiatric Research|January 5, 2002
A dose-ranging exploratory study of the effects of ethyl-eicosapentaenoate in patients with persistent schizophrenic symptomsMalcolm Peet, David F Horrobin, Archives of General Psychiatry|October 9, 2002
A dose-ranging study of the effects of ethyl-eicosapentaenoate in patients with ongoing depression despite apparently adequate treatment with standard drugsMalcolm Peet, David F HorrobinThe Journal of Nutrition|April 22, 2008
Long-chain polyunsaturated fatty acids modulate interleukin-1beta-induced changes in behavior, monoaminergic neurotransmitters, and brain inflammation in ratsCai Song, Mehar S Manku, David F HorrobinProstaglandins, Leukotrienes, and Essential Fatty Acids|August 11, 2004
A pilot open case series of ethyl-EPA supplementation in the treatment of anorexia nervosaAgnes K Ayton, Amer Azaz, David F HorrobinStress (Amsterdam, Netherlands)|June 19, 2004
Dietary ethyl-eicosapentaenoic acid but not soybean oil reverses central interleukin-1-induced changes in behavior, corticosterone and immune response in ratsCai Song, Brian E Leonard, David F HorrobinThe International Journal of Neuropsychopharmacology|March 9, 2004
Ethyl-eicosapentaenoate and dexamethasone resistance in therapy-refractory depressionHarald Murck, Cai Song, David F Horrobin, et al.Pageof 8